Excelsior Sciences

Excelsior Sciences is an AI-native biotechnology company that develops a proprietary platform for automated small molecule discovery and manufacturing using its 'blocc chemistry' approach. The company targets pharmaceuticals, materials science, and agtech to replace artisanal chemical synthesis with AI-guided, iterative automation. It generates value through a proprietary therapeutic pipeline and collaborative industry partnerships.